Search bioRxiv⌕ Search

Biology subjects

Linkohr, B.

Publications and source records attributed to Linkohr, B..

3 recordsLinked to original sources

Intraindividual longitudinal changes of the proteome reveal dynamic markers of biological aging

Proteomic aging clocks have emerged as biomarkers of aging, but most rely on cross-sectional data. Here, we present a proteomic aging clock based on longitudinal measurements of liquid chromatography-mass spectrometry plasma proteomics at up to three time points in the population-based KORA cohort, comprising 9,105 samples from 4,100 individuals in the final dataset aged 25-88 years. The model predicts chronological age and yields a measure of proteomic age acceleration associated with lifestyle and clinical risk factors. Risk factor-stratified analyses reveal shared proteomic signatures among cardiometabolic exposures and distinct signatures for smoking and physical activity. Within individuals, dyslipidemia and impaired kidney function track transitions to increases in age acceleration, while higher age acceleration is associated with increased all-cause mortality. Mediation analysis suggests that risk factors are linked to mortality indirectly through age acceleration. Affected proteins and pathways highlight extracellular matrix remodeling, complement and coagulation pathways, and liver-derived plasma proteins as key contributors to aging. Mendelian randomization identifies proteins with evidence consistent with a causal role in aging-related traits. Together, these findings are consistent with biological aging being dynamically responsive to changes in modifiable risk factors.

bioinformatics↗

CODI: Enhancing machine learning-based molecular profiling through contextual out-of-distribution integration

Molecular analytics increasingly utilize machine learning (ML) for predictive modeling based on data acquired through molecular profiling technologies. However, developing robust models that accurately capture physiological phenotypes is challenged by a multitude of factors. These include the dynamics inherent to biological systems, variability stemming from analytical procedures, and the resource-intensive nature of obtaining sufficiently representative datasets. Here, we propose and evaluate a new method: Contextual Out-of-Distribution Integration (CODI). Based on experimental observations, CODI generates synthetic data that integrate unrepresented sources of variation encountered in real-world applications into a given molecular fingerprint dataset. By augmenting a dataset with out-of-distribution variance, CODI enables an ML model to better generalize to samples beyond the initial training data. Using three independent longitudinal clinical studies and a case-control study, we demonstrate CODIs application to several classification scenarios involving vibrational spectroscopy of human blood. We showcase our approachs ability to enable personalized fingerprinting for multi-year longitudinal molecular monitoring and enhance the robustness of trained ML models for improved disease detection. Our comparative analyses revealed that incorporating CODI into the classification workflow consistently led to significantly improved classification accuracy while minimizing the requirement of collecting extensive experimental observations. SIGNIFICANCE STATEMENTAnalyzing molecular fingerprint data is challenging due to multiple sources of biological and analytical variability. This variability hinders the capacity to collect sufficiently large and representative datasets that encompass realistic data distributions. Consequently, the development of machine learning models that generalize to unseen, independently collected samples is often compromised. Here, we introduce CODI, a versatile framework that enhances traditional classifier training methodologies. CODI is a general framework that incorporates information about possible out-of-distribution variations into a given training dataset, augmenting it with simulated samples that better capture the true distribution of the data. This allows the classification to achieve improved predictive performance on samples beyond the original distribution of the training data.

bioinformatics↗

Arrhythmic gut microbiome signatures for risk profiling of Type-2 Diabetes

To combat the epidemic increase in Type-2-Diabetes (T2D), risk factors need to be identified. Diet, lifestyle and the gut microbiome are among the most important factors affecting metabolic health. We demonstrate in 1,976 subjects of a prospective population cohort that specific gut microbiota members show diurnal oscillations in their relative abundance and we identified 13 taxa with disrupted rhythmicity in T2D. Prediction models based on this signature classified T2D with an area under the curve of 73%. BMI as microbiota-independent risk marker further improved diagnostic classification of T2D. The validity of this arrhythmic risk signature to predict T2D was confirmed in 699 KORA subjects five years after initial sampling. Shotgun metagenomic analysis linked 26 pathways associated with xenobiotic, amino acid, fatty acid, and taurine metabolism to the diurnal oscillation of gut bacteria. In summary, we determined a cohort-specific risk pattern of arrhythmic taxa which significantly contributes to the classification and prediction of T2D, highlighting the importance of circadian rhythmicity of the microbiome in targeting metabolic human diseases.

microbiology↗